Hydroxocobalamin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Hydroxocobalamin Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Nov 4, 2024. Reported reason: Other
Shortage details
- Status
- Current
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 0591-2888-30
- Dosage Form
- Injection
- Presentation
- Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)
- Initial Posting
- Nov 4, 2024
Reason
Other